Cryo-Cell International (FRA:ZCY) Other Current Assets: €0.79 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZCY Cryo-Cell International Inc FRA:ZCY
57 GF Score
Price €2.74
GF Value €4.44
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Other Current Assets?

Cryo-Cell International FRA:ZCY +2.24% 57 Other Current Assets is €0.79 Mil as of May. 2026. GuruFocus rates FRA:ZCY with a GF Score™ of 57/100 and a GF Value™ of €4.44. The stock has 4 warning signs investors should review.

Cryo-Cell International's other current assets for the quarter that ended in May. 2026 was €0.79 Mil.

Cryo-Cell International's quarterly other current assets declined from Nov. 2025 (€1.04 Mil) to Feb. 2026 (€0.85 Mil) and declined from Feb. 2026 (€0.85 Mil) to May. 2026 (€0.79Mil).

Cryo-Cell International's annual other current assets declined from Nov. 2023 (€1.04 Mil) to Nov. 2024 (€1.03 Mil) increased from Nov. 2024 (€1.03 Mil) to Nov. 2025 (€1.04 Mil).


Cryo-Cell International Other Current Assets Related Terms


Cryo-Cell International Other Current Assets Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Other Current Assets Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.11 0.97 1.04 1.03 1.04

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.83 1.04 0.85 0.79
FRA:ZCY
57GF Score
Cryo-Cell International Inc FRA:ZCY
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of €0.79 Mil mean?
Cryo-Cell International (FRA:ZCY) has a Other Current Assets of €0.79 Mil as of May. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Cryo-Cell International.
Is Cryo-Cell International's Other Current Assets too high?
Cryo-Cell International's current Other Current Assets is €0.79 Mil. Overall, Cryo-Cell International has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Other Current Assets compare to EHSI and PIII?
Cryo-Cell International's Other Current Assets of €0.79 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Healthcare Providers & Services company?
A good Other Current Assets depends on the Healthcare Providers & Services industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Cryo-Cell International. Cryo-Cell International's current Other Current Assets is €0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Cryo-Cell International (FRA:ZCY) has a current Other Current Assets of €0.79 Mil. The stock's GF Value™ is €4.44, compared to a current price of €2.74 — trading 38.3% below its estimated fair value. The current Other Current Assets is €0.79 Mil. Cryo-Cell International's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Cryo-Cell International (FRA:ZCY), the current Other Current Assets is €0.79 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.74 is trading 38.3% below its estimated GF Value™ of €4.44.

Key valuation signals for FRA:ZCY:

  • Other Current Assets: €0.79 Mil
  • GF Value™: €4.44 vs. price of €2.74 (38.3% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
57GF Score

Get the complete analysis for FRA:ZCY

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.74
Price
€4.44
GF Value